Services to: 1) integrated EPR oximetry suite for epri at 400 MHZ frequency; 2) implementation of novel pulse programs for epri using waveform generator; 3) real time visualization of FT-EPR imaging…

Ended Purchase Order Awarded Last action

Contract number
HHSN261201600424P
Awardee
Awarding agency
Obligated
$62,073

Award facts

Opportunity
Contract value 100% obligated
$62,073.00 Current and potential, with all options
Completion date 100% complete
Current and potential, with all options
Set-aside
No set-aside
Competition
Not Competed under SAP · 1 offer Simplified Acquisition
Pricing
Firm Fixed Price
Place of performance
Bethesda, MD 20892, USA

Award details come from SAM.gov/FPDS.

Transactions

Action Obligated Date
Funding Only Action P00001 · DE-obligation of funds from FY2016 expiring lines. -$3,267
Original award $65,340

About this award

The National Cancer Institute awarded a purchase order to Genepria Consulting Inc. for $62,073 on July 1, 2016. The order covers development of an integrated electron paramagnetic resonance oximetry suite operating at 400 MHz, implementation of novel pulse programs using a waveform generator, real-time visualization of Fourier transform EPR imaging, algorithms for co-registration of 400 MHz EPR images with other imaging modalities, oximetry by T2* mapping using single spin-echo pulse imaging acquisition, and statistical analysis of gut microbiota 16S sequencing data from mice on Tempol feed. The order also addresses optimization of Fourier transform EPR imaging methods. Performance occurs in Bethesda, Maryland, with an ultimate completion date of March 14, 2021. The order is priced on a firm fixed-price basis with no set-aside designation.

Description

Services to: 1) integrated EPR oximetry suite for epri at 400 MHZ frequency; 2) implementation of novel pulse programs for epri using waveform generator; 3) real time visualization of FT-EPR imaging at 400 MHZ; 4) algorithms for CO-registration of images scanned by 400 MHZ epri with other modalities; 5) oximetry by T2* mapping using single SPI-epri acquisition at 400 MHZ; and 6) statistical analysis of GUT microbiota 16S sequencing data of mice on tempol feed.

Quick answers

Who was awarded contract HHSN261201600424P?

HHSN261201600424P was awarded to Genepria Consulting Inc. by National Cancer Institute (National Institutes of Health) on July 1, 2016.

How much is contract HHSN261201600424P worth?

The government has obligated $62,073 on HHSN261201600424P.

Was contract HHSN261201600424P competed?

The extent of competition for HHSN261201600424P was not competed under sap. The government received 1 offer.

On GovTribe

See this award's full record

  • Every transaction and funding action
  • The awardee's other awards and teaming partners
  • Similar awards and recompete opportunities
  • Ask GovTribe AI about this award